Clinician-Guided Microdosing for Metabolic Support
A physician‑led GLP‑1 microdosing program designed to support metabolic restoration, improve tolerance, reduce chronic inflammation and promote sustainable fat loss, without aggressive dose escalation.
Learn MoreSemaglutide Microdosing
A GLP-1 receptor agonist that supports appetite regulation, insulin sensitivity, and metabolic efficiency when introduced gradually.
Starter Program at
billed quarterly
Semaglutide Maintenance
Get 12 weeks of treatment with consultation, medication, and shipping all included. No membership required, with transparent pricing billed in convenient 3-month increments.
Tirzepatide Microdosing
A dual GIP/GLP-1 approach that supports appetite control and metabolic optimization with gradual, clinician-guided introduction.
Starter Program at
billed quarterly
Tirzepatide Maintenance
Get 12 weeks of treatment with consultation, medication, and shipping all included. No membership required, with transparent pricing billed in convenient 3-month increments.
Your Clinician-Guided Care
- Quick health and goals intake
- Clinician review and personalized GLP-1 microdosing plan
- If approved, medication shipped directly to your home
- Low-dose start with clear guidance
- Ongoing check-ins and dose adjustments
- Optional add-ons: hormone, peptide, and longevity support (where available)
Why a Microdosing Approach?
Improved Appetite Regulation
Gradual GLP-1 exposure may help support appetite signaling and satiety cues without abrupt suppression.
Reduced Gastrointestinal Discomfort
Micro-titration is designed to support tolerance by introducing medication slowly, which may help reduce common GI-related side effects.
Metabolic Calm
A gentler GLP-1 approach designed to support balanced metabolism and reduce low-grade metabolic stress linked to inflammation and fatigue.
Improved Metabolic Tolerance
Lower starting doses allow the body time to adapt, supporting metabolic responsiveness over time.
Lean Muscle Preservation
A gradual approach helps avoid aggressive caloric restriction, supporting lean mass retention when paired with appropriate nutrition.
Lower Rebound Risk After Discontinuation
Structured tapering and clinician oversight may help support metabolic stability when transitioning off therapy.
Understanding GLP-1 Microdosing
A Metabolic Optimization Approach to Inflammation, Energy, and Long-Term Health
Who May Benefit From a GLP-1 Microdosing Approach
Weight Loss + Maintenance
For patients starting weight loss support or transitioning into a maintenance phase after reaching a goal.
GI Sensitivity
For those who’ve felt nausea, bloating, or poor tolerability with standard GLP-1 dosing approaches.
Early Metabolic Syndrome
For signs of insulin resistance or early metabolic changes (including prediabetes or PCOS) that may benefit from clinician-guided support.
Hormonal Shifts
For thyroid, adrenal, or perimenopausal transitions where metabolism and appetite regulation may feel harder to manage.
Autoimmune or Inflammatory History
For individuals with an autoimmune or inflammatory history, evaluated carefully alongside the rest of your care plan.
Chronic Fatigue or Post-Viral States
For ongoing low energy or post-viral fatigue patterns, where a clinician may consider microdosing as part of a broader plan.
Eligibility varies by state and individual history. If prescribed, dosing and adjustments are managed by a licensed clinician.
Designed for Safety.
Guided by Clinicians.
Ideal candidates include adults with metabolic resistance, weight-management challenges, or GLP-1 intolerance at higher doses.Not suitable for individuals with contraindications to GLP-1 therapy, including certain endocrine or gastrointestinal conditions.All patients require a clinician's evaluation before a prescription is issued. Individual results may vary.
Check your eligibility
From the Ivologist Journal
Thoughts, tips, and clinical advice from the people who help you feel better, faster.
Testimonials
Our patients trust us because we combine real medicine with real care.
4.8(303 reviews)
Disclaimer
GLP-1 microdosing involves prescription medications and requires a medical evaluation. Compounded medications may be prepared by partner pharmacies and have not been reviewed or approved by the FDA. This content is for educational purposes only. Individual results may vary.
GLP-1 microdosing is a clinician-guided approach that uses lower, gradually adjusted doses of GLP-1 receptor agonists to support metabolic function. Instead of rapidly escalating to higher doses, microdosing focuses on helping the body adapt more comfortably over time.
Traditional GLP-1 programs often increase doses quickly, which may lead to side effects or poor tolerance for some patients. Microdosing uses smaller, incremental dose adjustments designed to improve tolerance, support metabolic adaptation, and promote long-term sustainability.
This program may be appropriate for adults who:
- Have struggled to tolerate higher GLP-1 doses
- Experience GI side effects with standard titration schedules
- Want a more gradual, metabolism-focused approach
- Are using or considering GLP-1s alongside hormone or longevity protocols
All patients must complete a medical evaluation to determine eligibility.
Depending on your clinician’s assessment, the program may include:
- Semaglutide, or
- Tirzepatide
Your provider will determine the appropriate medication, dosing schedule, and progression based on your health history and response.
Many patients report more natural, steady appetite regulation rather than abrupt suppression. Responses vary, and appetite changes may be more gradual compared to higher-dose protocols.
